You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
Virtual Activities of Living for Occupational Rehabilitation
SBC: BARRON ASSOCIATES INC Topic: NICHDPROJECT SUMMARY/ABSTRACT Introduction: The Virtual Activities of Living for Occupational Rehabilitation (VALOR) SBIR program will support telehealth delivery and remote monitoring of upper extremity (UE) stroke rehabilitation through the practice of virtual activities of daily living (ADLs) and instrumental ADLs (IADLs). The VALOR system marries ground- breaking untethered virtual reality (VR) hea ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Development and Validation of Cognitive Status Assessments in Older Adults Utilizing Conversational Agent Technology (CAT) Delivered on Smart Displays- the CAUCAT Study
SBC: WELLSAID.AI, LLC Topic: NIAPROJECT SUMMARY:Mild Cognitive Impairment (MCI), as well as Alzheimer’s Dementia and Related Dementias (ADRD) remain woefully under diagnosed. This is despite the availability of numerous scientifically validated screening instruments and recent financial incentives to physicians. This “evidence-practice” gap is at least in large part because available screening techniques are cumbersome to ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Micro-Organospheres Drug Screen to Lead Care (MODEL): a Precision Oncology Platform to Guide Breast Cancer Therapy
SBC: XILIS INC Topic: NCIPROJECT SUMMARY/ABSTRACT The goal of precision oncology is to match cancer patients with medicines based on the specific biology of their tumor. Crucially, the current precision oncology paradigm – which is largely based on tumor genomic profiling – doesn’t work for the majority of patients. Since every patient’s tumor is uniquely complex, a potential solution to this “precision” probl ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability
SBC: CYTOSORBENTS MEDICAL INC Topic: 300Rationale: Sepsis has been classified by the World Health Organization as a “global health priority.” It has been estimated that ~50% of patients with sepsis due to Gram-negative bacteria will develop septic shock and of these, half may die. There are currently no treatment options for attenuating the elevated inflammatory response and hemodynamic instability that is present in these patients. ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Interactive Cognitive Behavioral Therapy for Insomnia
SBC: Media Rez LLC Topic: 102ABSTRACT This study aims to further develop and test our voice-activated technology to deliver components of cognitive behavioral therapy for insomnia (CBT-I) to breast cancer survivors (BCS). CBT-I is a structured, systematic program which delivers better and safer outcomes than prescription sleep medications. Non-pharmacologic approaches target physiologic, cognitive, behavioral, environmental, ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening
SBC: DNASTAR, INC. Topic: NIAIDTherapeutic monoclonal antibodies bind to specific regions of proteins called epitopes, which elicit cellular responses that treat or cure disease. Discovering therapeutic antibodies traditionally requires laborious and expensive screening experiments, so computational approaches that select which antibodies bind an epitope best and have the most desirable pharmaceutical properties are in high dem ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Automated Ultra-Long DNA and RNA Extraction for Long-read Sequencing Applications
SBC: Claremont Biosolutions LLC Topic: 400Summary Claremont BioSolutions, LLC (CBIO) The ability to sequence and map long stretches of DNA and RNA using third generation sequencing technologies is set to transform the field of genomics and allow researchers and clinicians unparalleled insight into the complexities of our genome and diseases. However, the move to these platforms presents new hurdles in long DNA and RNA sample preparation. ...
SBIR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Leaflet sparing transcatheter aortic valve equipped with IVUS-guided delivery system.
SBC: VALVENTION INC Topic: NHLBIPROJECT SUMMARY/ABSTRACT Transcatheter aortic valve replacement (TAVR) is an essential alternative to surgical aortic valve replacement (SAVR) in elderly patients with aortic valve stenosis. At the current pace, TAVR procedures are expected to increase twofold from ~163,000 in 2020 to ~289,000 in 2025, and the number of patients with severe aortic stenosis is anticipated to rise to 3.5M by 2050. G ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Development of an Instant Freezing Sample Preparation System for Cryo-EM
SBC: Hummingbird Precision Machine Co. Topic: 400Project Summary Project Title: Development of an Instant Freezing Sample Preparation System for Cryo-EM Company Name: Hummingbird Precision Machine Co., dba Hummingbird Scientific Principal Investigator: Norman Salmon Summary: The field of cryogenic electron microscopy (cryo-EM) has rapidly been gaining traction as a structural characterization technique for proteins. Sample preparation for cryo-E ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Brain-enriched microRNAs detectable in plasma as biomarkers of Alzheimer's Disease
SBC: DIAMIR, LLC Topic: NIASUMMARY One in 10 Americans aged 65 and older have Alzheimer’s disease (AD). Since AD begins with a prolonged, over 10 year-long, asymptomatic stage, a growing number of companies are developing new therapies that aim to intervene early in the progression of AD and related forms of dementia. There is thus a great need for minimally invasive diagnostic tools for primary screening of individuals w ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health